HomeIMCR • NASDAQ
add
Immunocore Holdings PLC - ADR
Nakaraang pagsara
$30.61
Sakop ng taon
$23.15 - $62.74
Market cap
1.53B USD
Average na Volume
409.64K
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 84.05M | 19.80% |
Gastos sa pagpapatakbo | 232.68M | 19.83% |
Net na kita | -23.77M | -20.48% |
Net profit margin | -28.28 | -0.57% |
Kita sa bawat share | -0.47 | -17.50% |
EBITDA | -235.00K | 98.61% |
Aktuwal na % ng binabayarang buwis | 4.23% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 820.38M | 85.34% |
Kabuuang asset | 1.01B | 69.10% |
Kabuuang sagutin | 648.79M | 184.36% |
Kabuuang equity | 360.72M | — |
Natitirang share | 50.07M | — |
Presyo para makapag-book | 4.25 | — |
Return on assets | -0.33% | — |
Return on capital | -0.42% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -23.77M | -20.48% |
Cash mula sa mga operasyon | -13.95M | 21.33% |
Cash mula sa pag-invest | -3.54M | -333.29% |
Cash mula sa financing | -51.51M | -923.65% |
Net change in cash | -82.04M | -5,325.66% |
Malayang cash flow | -10.20M | -65.73% |
Tungkol
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology. Wikipedia
Itinatag
2008
Website
Mga Empleyado
493
